These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31818276)

  • 1. Autoregressive modeling to assess stride time pattern stability in individuals with Huntington's disease.
    Alzakerin HM; Halkiadakis Y; Morgan KD
    BMC Neurol; 2019 Dec; 19(1):316. PubMed ID: 31818276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time series modeling characterizes stride time variability to identify individuals with neurodegenerative disorders.
    Halkiadakis Y; Davidson N; Morgan KD
    Hum Mov Sci; 2023 Dec; 92():103152. PubMed ID: 37898010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal gait characteristics of Huntington's disease during dual-task walking.
    Radovanović S; Vodopić S; Stanković I; Dragašević-Mišković N; Kostić V
    Int J Neurosci; 2020 Feb; 130(2):136-143. PubMed ID: 31516046
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterizing gait pattern dynamics during symmetric and asymmetric walking using autoregressive modeling.
    Mahzoun Alzakerin H; Halkiadakis Y; Morgan KD
    PLoS One; 2020; 15(12):e0243221. PubMed ID: 33270770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait variability as digital biomarker of disease severity in Huntington's disease.
    Gaßner H; Jensen D; Marxreiter F; Kletsch A; Bohlen S; Schubert R; Muratori LM; Eskofier B; Klucken J; Winkler J; Reilmann R; Kohl Z
    J Neurol; 2020 Jun; 267(6):1594-1601. PubMed ID: 32048014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of dual-task cognitive interference on gait and turning in Huntington's disease.
    Purcell NL; Goldman JG; Ouyang B; Liu Y; Bernard B; O'Keefe JA
    PLoS One; 2020; 15(1):e0226827. PubMed ID: 31910203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a disorder of locomotor timing in Huntington's disease.
    Bilney B; Morris ME; Churchyard A; Chiu E; Georgiou-Karistianis N
    Mov Disord; 2005 Jan; 20(1):51-7. PubMed ID: 15390128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into gait disorders: walking variability using phase plot analysis, Huntington's disease.
    Collett J; Esser P; Khalil H; Busse M; Quinn L; DeBono K; Rosser A; Nemeth AH; Dawes H
    Gait Posture; 2014 Sep; 40(4):694-700. PubMed ID: 25172806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of attentional resources on gait performance in Huntington's disease.
    Delval A; Krystkowiak P; Delliaux M; Dujardin K; Blatt JL; Destée A; Derambure P; Defebvre L
    Mov Disord; 2008 Apr; 23(5):684-9. PubMed ID: 18175353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
    Delval A; Krystkowiak P; Blatt JL; Labyt E; Dujardin K; Destée A; Derambure P; Defebvre L
    J Neurol; 2006 Jan; 253(1):73-80. PubMed ID: 16096818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait in Huntington's disease and the stride length-cadence relationship.
    Danoudis M; Iansek R
    BMC Neurol; 2014 Oct; 14():161. PubMed ID: 25265896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate effects of treadmill walking in individuals with Lewy body dementia and Huntington's disease.
    Kegelmeyer DA; Kostyk SK; Fritz NE; Scharre DW; Young GS; Tan Y; Schubert R; Reilmann R; Kloos AD
    Gait Posture; 2021 May; 86():186-191. PubMed ID: 33756407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease.
    Hausdorff JM; Cudkowicz ME; Firtion R; Wei JY; Goldberger AL
    Mov Disord; 1998 May; 13(3):428-37. PubMed ID: 9613733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairments in Spatiotemporal Gait Adaptation During Obstacle Navigation in Huntington's Disease.
    Anwar N; Labuschagne I; Simpson K; Smith L; Georgiou-Karistianis N
    Neurorehabil Neural Repair; 2017; 31(10-11):934-943. PubMed ID: 29082783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered fractal dynamics of gait: reduced stride-interval correlations with aging and Huntington's disease.
    Hausdorff JM; Mitchell SL; Firtion R; Peng CK; Cudkowicz ME; Wei JY; Goldberger AL
    J Appl Physiol (1985); 1997 Jan; 82(1):262-9. PubMed ID: 9029225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of Gait Parameters in Huntington's Disease Using Wearable Sensors in the Clinic and Free-living Conditions.
    Lozano-Garcia M; Doheny EP; Mann E; Morgan-Jones P; Drew C; Busse-Morris M; Lowery MM
    IEEE Trans Neural Syst Rehabil Eng; 2024; 32():2239-2249. PubMed ID: 38819972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregressive Modeling as Diagnostic Tool to Identify Postanterior Cruciate Ligament Reconstruction Limb Asymmetry.
    Morgan KD
    J Appl Biomech; 2019 Dec; 35(6):388–392. PubMed ID: 31629340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of spatiotemporal gait outcome measures in Huntington's disease.
    Rao AK; Quinn L; Marder KS
    Mov Disord; 2005 Aug; 20(8):1033-7. PubMed ID: 15838854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Locomotion disturbances in Huntington's disease].
    Delval A; Krystkowiak P
    Rev Neurol (Paris); 2010 Feb; 166(2):213-20. PubMed ID: 19604530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of external cueing on gait in Huntington's disease.
    Delval A; Krystkowiak P; Delliaux M; Blatt JL; Derambure P; Destée A; Defebvre L
    Mov Disord; 2008 Jul; 23(10):1446-52. PubMed ID: 18512747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.